SCH: Context-aware Freezing of Gait Mitigation in Real-world Setting
Part of paid clinical trials in Richmond, Virginia.
- Sponsor
- Virginia Commonwealth University
- Study ID
- NCT04746846
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- UG motion sensor with PDVibe3 — DEVICEUG motion sensor (which detects FoG) on worn each ankle. PDVibe3 (which provides vibration) on worn each ankle
Study Details
People with Parkinson's disease (PD) may experience a walking problem called freezing of gait (FoG) that can interfere with the person's ability to conduct daily activities. FoG has been described as feeling like one's feet are glued or stuck to the floor. Drug treatments for PD rarely improve FoG. Researchers have found that vibration therapy may help improve FoG. The purpose of this research study is to test the safety, tolerability, and effectiveness of using a wearable device (UG motion sensor, that is the size of a watch) that will recognize FoG and then send a signal to another small watch-like device (PDVibe3) to deliver a vibration stimuli to participant's feet. The researchers believe the vibration stimulus (which feels like a phone on vibration mode) will help reduce FoG in persons with PD. The study is open to people who have been diagnosed with Parkinson's disease, have FoG, and meet the study entry requirements. The PDVibe3 is an investigational device, which means it has not been approved by the U.S. Food and Drug Administration (FDA). The UG motion sensor is also an investigational device.
Key Dates
- Start date
- Jun 11, 2021
- Status verified
- Aug 2025
- Primary completion
- Mar 10, 2025
- Completion
- Mar 10, 2025
Study Design
- Enrollment
- 12 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Vibration therapy5-meter walk scenarios with vibration therapy
Primary Outcome Measure
Number of Freezing of Gait (FoG) Episodes [ Time Frame: Baseline to final walk task - up to 5 hours ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Virginia Commonwealth University | Richmond | Virginia | 23298 | - |
Find similar trials in Richmond, VA
Related Studies
- A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's DiseasePHASE2 · Recruiting · Neuron23 Inc. · Sun City, Arizona
- A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's DiseasePHASE4 · Recruiting · Impax Laboratories, LLC · Phoenix, Arizona
- Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)Recruiting · University of Virginia · Charlottesville, Virginia
- Genetic Studies of Lysosomal Storage DisordersEnrolling By Invitation · National Human Genome Research Institute (NHGRI) · Bethesda, Maryland